4//SEC Filing
Altus Pharmaceuticals Inc. 4
Accession 0001209191-07-055589
CIK 0001340744operating
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:24 PM ET
Size
9.1 KB
Accession
0001209191-07-055589
Insider Transaction Report
Form 4
Gallotto Robert
VP, Strategic Planning
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2007-10-01−500→ 29,322 totalExercise: $3.92From: 2002-12-20Exp: 2012-12-19→ Common Stock (500 underlying) - Sale
Common Stock
2007-10-01$10.56/sh−500$5,280→ 0 total - Exercise/Conversion
Common Stock
2007-10-01$3.92/sh+500$1,960→ 500 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Gallotto on September 1, 2006.
- [F2]All of such options have a term of ten years vesting over four years, with 1/16 of the options vesting every three months.
Documents
Issuer
Altus Pharmaceuticals Inc.
CIK 0001340744
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001340744
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:24 PM ET
- Size
- 9.1 KB